Findings on value creation and regulatory fit offer far-ranging implications for management, marketing and even mental health.
Will the cost of overhauling the health care system take an undue toll on small businesses? Professor Rita McGrath says that could be the case.
At Columbia Business School's 5th Annual Healthcare Conference, industry leaders said they are looking for ways to drive innovation.
Will a new bubble form in 2010? What will happen to the retail market? Faculty members share their predictions for the year ahead.
New drugs and medical procedures account for much of the increase in the longevity of Americans — and haven’t increased the cost of care.
Warren Buffett, MS '51, and Bill Gates spent an hour answering students' questions in a community forum on November 12. A major theme of the conversation was optimism about U.S. economic prosperity in the long-term.
Dean Glenn Hubbard explains five reforms to the U.S. health care system that may save as much as $60 billion a year while extending coverage and increasing consumer choice.
A mathematical model helps doctors offer every patient a same-day appointment.
Cliff Cramer, who directs the School’s new Program in Healthcare and Pharmaceutical Management, explains how a multidisciplinary business education can help mend an increasingly convoluted and flawed industry.
Professor Andrew Schmidt discusses the impact of Obama's proposed tax code changes. What industries will be affected?
From the Archive: A new decision model could help ICUs treat more patients without adding beds or sacrificing quality of care.
Professor Frank Lichtenberg explains how expanded health insurance coverage is an economic value proposition.
"It's incredibly difficult to be a part-time entrepreneur. To do well, I believe you have to immerse yourself in your work. You have to go all in."
From the Archive, December 2007: Using smoking as a proxy for time preference may help explain why some workers invest more in career development than others.
Can research from management science and marketing help explain - and possibly treat - depression and anxiety?
Traditional supply chain models emphasize the benefits of consolidating production. But as Awi Federgruen explains, the recent flu vaccine crisis illustrates the risks of relying too heavily on a single supplier.
Nachum Sicherman, who has researched cost-benefit analysis in medical decision making, delves into the economic angles of the city’s controversial public health regulation.
Rich and poor alike — even those who pay the highest prices — can be better off when pharmaceutical firms serve different markets at different rates.
With 32 million people expected to gain access to insurance coverage, what is the long-term economic prospect? Professor Frank Lichtenberg explains why insurance is a good investment.
At the 6th Annual Healthcare Conference, industry leaders said they are focused on innovation, value-rich offerings and the emergence of new global markets and technologies.
On November 12, Columbia Business School students will join Warren Buffett, MS '51, and Bill Gates in a special community forum, which will be filmed by CNBC for global broadcast.
Jeff Kindler, chairman and CEO of Pfizer, spoke with students about the company's merger with Wyeth and its strategies for confronting market challenges. Read more about the discussion.
A queuing model for nurse staffing can cut costs and improve patient care.
Columbia Senior Executive Program 2 x 2
The article features research by Prof. Green that examines how physician shortages could be eliminated.
In an article for the Wall Street Journal, Prof. Federgruen argues that government price controls are the primary reason for the decline in the number of suppliers, drug shortages in the US.
Industry practitioners, alumni, students, and staff and faculty members gathered together for the ninth annual Columbia Business School Healthcare Conference on November 30 in New York City.
New research from Columbia Business School warns that consumers will make mistakes totaling $9 billion; offers prescriptions to help improve consumer experience using new state healthcare exchanges
Enhancing Your Career Success in a Multi-Generational Workplace
The article features research by Prof. Johnson that predicts consumers, who will select new health care plans under the Affordable Care Act, will have trouble selecting the most cost effective health care plans.
Alumni panel on Healthcare and Private Equity
Surya N. Mohapatra, former chairman and chief executive officer of Quest Diagnostics Incorporated, has been named Executive in Residence at Columbia Business School.
Research reveals role of government funding in pharmaceutical R&D and its direct and indirect impact on innovative new drugs
Sergio Marchionne, CEO of Fiat and Chrysler Group, and Brent James, MD, chief quality officer of Intermountain Healthcare, were honored on Wednesday, November 2, as recipients of Columbia Business School’s second annual Deming Cup awards.
Model depicts that detailing, relationships between sales representatives and medical doctors, is an extremely effective long–term marketing tool, while sampling has a stronger, short–term effect
Student Profile: Omar Haroun '12, Founder of Sportaneous